EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters

Nicola Edith von Ostau, Analena Elisa Handke, Manuel Wiesenfarth, Peter Albers, Gerald Antoch, Joachim Noldus, Henning Reis, Cristina Cotarelo, Julia Preetz, Lale Umutlu, Marc Ingenwerth, Jan Philipp Radtke und 3 weitere

World Journal of Urology · 2024

DOI: 10.1007/s00345-024-05232-6 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift World Journal of Urology, 2024. Verfasst von Nicola Edith von Ostau und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany. nicola.vonostau@uk-essen.de. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Neoplasm Invasiveness, Prostatectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to validate a previously published risk model (RM) which combines clinical and multiparametric MRI (mpMRI) parameters to predict extraprostatic extension (EPE) of prostate cancer (PC) prior to radical prostatectomy (RP). Materials and methods A previously published RM combining clinical with mpMRI parameters including European Society of Urogenital Radiology (ESUR) classification for EPE was retrospectively evaluated in a cohort of two urological university hospitals in Germany. Consecutive patients ( n = 205, January 2015 –June 2021) with available preoperative MRI images, clinical information including PSA, prostate volume, ESUR classification for EPE, histopathological results of MRI-fusion biopsy and RP specimen were included. Validation was performed by receiver operating characteristic analysis and calibration plots. The RM‘s performance was compared to ESUR criteria.

Results

Histopathological T3 stage was detected in 43% of the patients ( n = 89); 45% at Essen and 42% at Düsseldorf. Discrimination performance between pT2 and pT3 of the RM in the entire cohort was AUC = 0.86 (AUC = 0.88 at site 1 and AUC = 0.85 at site 2). Calibration was good over the entire probability range. The discrimination performance of ESUR classification alone was comparable (AUC = 0.87).

Conclusions

The RM showed good discriminative performance to predict EPE for decision-making for RP as a patient-tailored risk stratification. However, when experienced MRI reading is available, standardized MRI reading with ESUR scoring is comparable regarding information outcome. A main limitation is the potentially limited transferability to other populations because of the high prevalence of EPE in our subgroups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMultiparametric Magnetic Resonance ImagingNeoplasm InvasivenessProstatectomyHumansMaleRetrospective StudiesRisk AssessmentMiddle AgedAgedPredictive Value of TestsPreoperative Care

Stichwörter der Autor:innen

Extraprostatic extensionMultiparametric MRIPositive surgical marginsProstate cancer

Autor:innen und Institutionen

  • Department of Urology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany. nicola.vonostau@uk-essen.de.
  • Department of Urology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
  • Department of Urology, Ruhr-University Bochum, Marien Hospital, Herne, Germany.
  • Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
  • Department of Urology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Medical Faculty, Department of Diagnostic and Interventional Radiology, University Düsseldorf, D-40225, Dusseldorf, Germany.

Förderung

  • Universitätsklinikum Essen

Zitieren

APA

Ostau, N. E. V., Handke, A. E., Wiesenfarth, M., Albers, P., Antoch, G., Noldus, J., Reis, H., Cotarelo, C., Preetz, J., Umutlu, L., Ingenwerth, M., Radtke, J. P., Hadaschik, B., Schimmöller, L., & Kesch, C. (2024). Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters. World Journal of Urology. https://doi.org/10.1007/s00345-024-05232-6

Vancouver

Ostau NEV, Handke AE, Wiesenfarth M, Albers P, Antoch G, Noldus J, et al. Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters. World Journal of Urology. 2024. doi:10.1007/s00345-024-05232-6

BibTeX
@article{Ostau2024,
  author = {Ostau, Nicola Edith von and Handke, Analena Elisa and Wiesenfarth, Manuel and Albers, Peter and Antoch, Gerald and Noldus, Joachim and Reis, Henning and Cotarelo, Cristina and Preetz, Julia and Umutlu, Lale and Ingenwerth, Marc and Radtke, Jan Philipp and Hadaschik, Boris and Schimmöller, Lars and Kesch, Claudia},
  title = {Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters},
  journal = {World Journal of Urology},
  year = {2024},
  doi = {10.1007/s00345-024-05232-6}
}
Kostenlos starten →